MAM
EUME teams up with CSK and RCB as official mask partner
NEW DELHI: Chennai Super Kings and Royal Challengers Bangalore have partnered with popular lifestyle brand EUME as their official mask partner for the upcoming 2020 Indian Premier League (IPL) season. The association will see CSK players and their support staff wear EUME masks. A well-known brand for its worldwide patented massager backpack, EUME launched a wide range of high-grade masks in the wake of the Covid2019 pandemic.
The lifestyle brand teamed up with the two leading IPL teams to keep their cricketers safe during IPL-13 to be played in the UAE between 19 September and 10 November. The brand has also unveiled special edition masks for CSK and RCB fans, similar to the ones worn by their players. The masks are available on all leading e-commerce platforms and EUME’s website.
EUME founder & director Naina Parekh said, “We are extremely honored to have inked this historic association with MS Dhoni-led Chennai Super Kings. We are delighted that our masks shall play a pivotal role in keeping the teams safe during the pandemic while significantly contributing to the sporting community. Our masks are armed with 4 ply shields that make it pollution, dust, and bacteria-resistant while also keeping it easy to wear for outdoor activities.”
The IPL is the one of most-watched sporting events in the country. Cricket fans across the globe will again tune in to this year’s edition of the most popular T20 league in the world.
“It’s essential to wear a high-grade mask during the pandemic. EUME’s advanced technology keeps you safe and their aesthetically designed masks are easy to wear during outdoor activities,” CSK CEO KS Viswanathan said.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
